ReviewInternational journal of molecular sciences2022

Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy.

Manuela Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.